Indication

Meningococcal immunization

1 clinical trial

2 products

Clinical trial

Phase I Study of the Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y and W-135) Polysaccharide Tetanus Protein Conjugate Vaccine in Adults, Toddlers, and Infants

Status: Completed, Estimated PCD: 2008-08-27

Product

Meningococcal Group C-CRM197 Conjugate Vaccine

Product